Remedy Robotics Partners with Mission Thrombectomy
Remedy Robotics has entered a strategic partnership with Mission Thrombectomy, a leading clinician network dedicated to accelerating access to endovascular thrombectomy in stroke.
The partnership aims to expand access to thrombectomy in the U.S. and globally using the Remedy Robotics N1 system, a remotely operable endovascular robot that combines proprietary hardware and AI-enabled software.
According to Remedy Robotics, the N1 system enables faster, safer, and more effective innovation in cardiovascular conditions.
This partnership marks the second such collaboration for the company in recent weeks, following a deal with the Australian Stroke Alliance.
Remedy Robotics touts N1 as the world’s first remotely operable endovascular robot.
- Partnership expands access to thrombectomy in the U.S. and globally
- N1 system combines proprietary hardware and AI-enabled software
- Second partnership for Remedy Robotics in recent weeks
Author's summary: Remedy Robotics partners with Mission Thrombectomy to expand access to thrombectomy.
More News
- Olofsson, Wedgewood lead Avalanche past Lightning 3-2 in rematch of 2022 final
- The story LI's election numbers tell so far
- Who went home on 'Dancing with the Stars'? Elimination surprise on Rock & Roll Hall of Fame Night
- Suffolk voters [reject/approve] ballot measure extending length of county legislative terms
- Schmid makes 24 saves, Barbashev scores in Golden Knights' 1-0 victory over Red Wings
- Movate and Lyzr.ai Announce Strategic Partnership to Accelerate Enterprise AI Transformation - Netindia123.com
- How is climate change affecting the property market? | Climate Council
- Queens lawmaker elected mayor — Queens Daily Eagle
- Editorial: Federal food stamp funding and Nassau County
- Gov. Wes Moore starts Maryland redistricting efforts amid national voter map battle